Lessons learned from the analysis of gender effect on risk factors and procedural outcomes of lower extremity arterial disease

Journal of Vascular Surgery

Volumn 52, Issue 5, 2010, Pages 1196-1202

  Vouyouka, Ageliki G ^a   Egorova, Natalia N ^a   Salloum, Alexander ^a   Kleinman, Lawrence ^a   Marin, Michael ^a   Faries, Peter L ^a   Moscowitz, Allan ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CRITICAL LIMB ISCHEMIA; ENDOVASCULAR SURGERY; FEMALE; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTERMITTENT CLAUDICATION; LEG AMPUTATION; LEG REVASCULARIZATION; LOWER EXTREMITIES PERIPHERAL ARTERIAL DISEASE; LUNG COMPLICATION; MAJOR CLINICAL STUDY; MALE; NEGRO; OBESITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REFERENCE DATABASE; SEX DIFFERENCE; SHOCK; SMOKING; STROKE; SURGICAL MORTALITY; VASCULAR SURGERY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DATA BASE; HEALTH DISPARITY; LEG; MORTALITY; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UNITED STATES; VASCULARIZATION; WOMEN'S HEALTH;

AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; DATABASES AS TOPIC; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; LOGISTIC MODELS; LOWER EXTREMITY; MALE; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VASCULAR SURGICAL PROCEDURES; WOMEN'S HEALTH;

EID: 79952108600     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.05.106     Document Type: Article

References (42)

1. Hultgren R, Sjogren B, Soderberg M, Takolander R, Wahlberg E, Wahlberg M, et al. Sexual function in women suffering from aortoiliac occlusive disease. Eur J Vasc Endovasc Surg 1999;17:306-12.
2. Higgins J, Higgins J. Epidemiology of peripheral arterial disease in women. J Epidemiol 2003;13:1-14.
3. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;110: 738-43.
4. Zheng ZJ, Rosamond WD, Chambless LE, Nieto FJ, Barnes RW, Hutchinson RG, et al. Lower extremity arterial disease assessed by ankle-brachial index in a middle-aged population of African Americans and whites: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Prev Med 2005;29(5 Suppl 1):42-9.
5. Egorova N, Vouyouka AG, Quin J, Guillerme S, Moskowitz A, Marin M, et al. Analysis of gender-related differences in lower extremity peripheral arterial disease: 1998-2007. J Vasc Surg 2010;51:372-8.e1; discussion 378-9.
6. Nowygrod R, Egorova N, Greco G, Anderson P, Gelijns A, Moskowitz A, et al. Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg 2006;43:205-16.
7. Cheanvechai V, Harthun NL, Graham LM, Freischlag JA, Gahtan V. Incidence of peripheral vascular disease in women: is it different from that in men? J Thorac Cardiovasc Surg 2004;127:314-7.
8. DeRubertis BG, Vouyouka A, Rhee SJ, Califano J, Karwowski J, Angle N, et al. Percutaneous intervention for infrainguinal occlusive disease in women: equivalent outcomes despite increased severity of disease compared with men. J Vasc Surg 2008;48:150-7; discussion 157-8.
9. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
10. Stefanska A, Sypniewskay G, Senterkiewicz L. Inflammatory markers and cardiovascular risk in healthy Polish women across the menopausal transition. Clin Chem 2005;51:1893-5.
11. Vural P, Canbaz M, Akgul C. Effects of menopause and postmenopausal tibolone treatment on plasma TNFa, IL-4, IL-10, IL-12 cytokine pattern and some bone turnover markers. Pharmacol Res 2006;53: 367-71.
12. VouyoukaAG, KentKC. Arterial vascular disease in women. JVasc Surg 2007;46:1295-1302.
13. Bell FC WA, Goss SC. Life Tables for the United States Social Security Area 1900-2080. Baltimore: Social Security Administration, Office of the Actuary. Vol Actuarial Study No 107; 1992.
14. Lakdawalla Darius PT. Aging and the growth of long-term care. National Bureau of Economic Research (NBER); 1999.
15. Houser AN. Women and long-term care research report. AARP Public Policy Institute; 2007.
16. Beedon L, Wu KB. Women age 65 and older: their sources of income. AARP Public Policy Institute; 2005.
17. Eslami MH, Zayaruzny M, Fitzgerald GA. The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia. J Vasc Surg 2007;45:55-9.
18. Vogt MT, Cauley JA, Kuller LH, Nevitt MC. Functional status and mobility among elderly women with lower extremity arterial disease: the Study of Osteoporotic Fractures. J Am Geriatr Soc 1994;42:923-9.
19. von Muhlen D, Allison M, Jassal SK, Barrett-Connor E. Peripheral arterial disease and osteoporosis in older adults: the Rancho Bernardo Study. Osteoporos Int 2009;20:2071-8.
20. Belkin M, Conte MS, Donaldson MC, Mannick JA, Whittemore AD. The impact of gender on the results of arterial bypass with in situ greater saphenous vein. Am J Surg 1995;170:97-102.
21. Frangos SG, Kilaru S, Sumpio BE, Gahtan V. Effect of gender on outcome following infrainguinal bypass graft surgery: a systematic review. Conn Med 2002;66:137-44.
22. Harris EJ Jr, Taylor LM Jr, Moneta GL, Porter JM. Outcome of infrainguinal arterial reconstruction in women. J Vasc Surg 1993;18: 627-34; discussion 634-26.
23. Kalman PG, Johnston KW. Predictors of long-term patient survival after in situ vein leg bypass. JVasc Surg 1997;25:899-904.
24. Mays BW, Towne JB, Fitzpatrick CM, Smart SC, Cambria RA, Seabrook GR, et al. Women have increased risk of perioperative myocardial infarction and higher long-term mortality rates after lower extremity arterial bypass grafting. JVasc Surg 1999;29:807-12; discussion 812-03.
25. Magnant JG, Cronenwett JL, Walsh DB, Schneider JR, Besso SR, Zwolak RM. Surgical treatment of infrainguinal arterial occlusive disease in women. JVasc Surg 1993;17:67-76; discussion 76-68.
26. Abando A, Akopian G, Katz SG. Patient sex and success of peripheral percutaneous transluminal arterial angioplasty. Arch Surg 2005;140: 757-61.
27. Timaran CH, Stevens SL, Grandas OH, Piercy KT, Freeman MB, Goldman MH. Influence of hormone replacement therapy on graft patency after femoropopliteal bypass grafting. J Vasc Surg 2000;32: 506-16; 516-08.
28. Timaran CH, Stevens SL, Grandas OH, Freeman MB, Goldman MH. Influence of hormone replacement therapy on the outcome of iliac angioplasty and stenting. J Vasc Surg 2001;33(2 Suppl):S85-92.
29. Mikhail GW. Coronary heart disease in women. BMJ 2005;331:467-8.
30. Enriquez JR, Pratap P, Zbilut JP, Calvin JE, Volgman AS. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins. Gend Med 2008;5:53-61.
31. Miller M, Byington R, Hunninghake D, Pitt B, Furberg CD. Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Investigators. Arch Intern Med 2000;160: 343-7.
32. Fuchs S, Kornowski R, Teplitsky I, Brosh D, Lev E, Vaknin-Assa H, et al. Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications. Cardiovasc Revasc Med 2009;10:88-93.
33. Argulian E, Patel AD, Abramson JL, Kulkarni A, Champney K, Palmer S, et al. Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. Am J Cardiol 2006;98:48-53.
34. Dauerman HL, Andreou C, Perras MA, Spinner JS, Lessard D, Weiner BH. Predictors of bleeding complications after rescue coronary interventions. J Thromb Thrombolysis 2000;10:83-8.
35. Feit F, Voeltz MD, Attubato MJ, Lincoff AM, Chew DP, Bittl JA, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol 2007;100:1364-9.
36. Manoukian SV, Voeltz MD, Eikelboom J. Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk. Clin Cardiol 2007;30(10 Suppl 2):II24-34.
37. Campbell HC, Hubbard SG, Ernst CB. Continuous heparin anticoagulation in patients with arteriosclerosis and arterial emboli. Surg Gy-necol Obstet 1980;150:54-6.
38. Campbell FW, Tyson GS, Gravlee GP, Horrow JC, Tuman KJ. Case 4-1990. A 66-year-old woman who is taking aspirin continues to bleed after routine care. J Cardiothorac Anesth 1990;4:499-517.
39. Cheng S, Morrow DA, Sloan S, Antman EM, Sabatine MS. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction. Circulation 2009;119: 1195-1202.
40. Roddy SP, Darling RC III, Maharaj D, Chang BB, Paty PS, Kreienberg PB, et al. Gender-related differences in outcome: an analysis of 5880 infrainguinal arterial reconstructions. J Vasc Surg 2003;37:399-402.
41. Wengrovitz M, Atnip RG, Gifford RR, Neumyer MM, Heitjan DF, Thiele BL. Wound complications of autogenous subcutaneous infrain-guinal arterial bypass surgery: predisposing factors and management. J Vasc Surg 1990;11:156-61; discussion 161-53.
42. Nam JH, Gahtan V, Roberts AB, Kerstein MD. Influence of incisional complications on infrainguinal vein bypass graft outcome. Ann Vasc Surg 1999;13:77-83.